Michael Mangus
Golden engineer. Former tech coordinator for UCSB Media Neuroscience Lab (PhD '15). Computational social scientist. NDT/CEDA 2A/1N. Patzer.
Joined April 2017
DemonporeArticle (+6/-6 characters)
One of the founders of Demonpore, Kent Kemmish, was part of and helped recruit the early team of Synthego, Inc., now a unicorn in the CRISPRCRISPR sphere.
Article (+8/-8 characters)
One of the founders of Demonpore, Kent Kemmish, was part of and helped recruit the early team of SynthegoSynthego, Inc., now a unicorn in the CRISPR sphere.
Article (+12/-12 characters)
One of the founders of Demonpore, Kent KemmishKent Kemmish, was part of and helped recruit the early team of Synthego, Inc., now a unicorn in the CRISPR sphere.
Max Yankelevich
Max Bernardy
Verifi Media
Verifi Media
Infobox
Adobe IllustratorInfobox
Infobox
Adobe Spark
ConcentrixInfobox
Website
Asdf Asdf Asdf Asdf Santa e Pecadora
PrimeVax Immuno-OncologyTimeline (+1 events) (+211 characters)
January 22, 2019
PrimeVax Immuno-Oncology, Inc. announced an exclusive, worldwide license with the US Army Medical Materials Development Activity authorizing PrimeVax to use dengue virus-1 #45AZ5 strain for treatment of cancer
Abalone Bio, IncInfobox
Location